DECEMBER 2022LIFE SCIENCES REVIEW6Proteomics is often used in clinical research as a tool for exploring cellular pathways and disease processes. Clinical proteomics can be divided into two areas: expression proteomics and functional proteomics. Expression proteomics compares the differential expression between proteomes of cells, tissues, or organisms to a control proteome in an experimental condition. Functional proteomics explores how protein modifications and interactions affect protein function during physiological and pathological conditions.Information about the protein that may be useful in the study of proteomics includes the affluence, variations, alterations and partners or networks of the protein being studied. These findings can help to improve our understanding of the structure, function and interactions of all of the proteins that exist within a specific organism.Over the past decade, technological advances in mass spectrometry and bioinformatics have facilitated novel applications of clinical proteomics in biomarker discovery, drug development, and disease etiology.Technical advances in mass spectrometry and machine learning promise to transform personalized medicine. However, challenges in sample preparation and lack of standardization of the analytical procedures and workflows hamper widespread use of mass spectrometry in clinical laboratories. Unless these challenges are addressed, proteomics will continue to be used as a preclinical hypothesis-generating tool instead of a widely accepted clinical diagnostic.It is important for proteomics research to focus on the behaviour of proteins in a real life environment and for each study to be considered in the context of its environment. At present, in the field of proteomics, the environmental context is not well addressed, despite its importance. This is expected to have greater priority as the study of proteomics progresses. For example, the increasing use of chemical cross-linkers in proteomics may help to improve this issue.The proteome of human plasma holds insight about the physiological wellbeing of all other tissues within the body and is easily accessible for testing from individuals. Therefore, if the proteome can be established the information would be invaluable for medical purposes and could potentially be used as a diagnostic tool for a wide range of health conditions.Let us know your thoughts.EDITORIALThe Novel World of ProteomicsCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com DECEMBER - 01 - 2022, Vol 03, Issue - 38 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsVictor Cruz Clara Matthew
< Page 5 | Page 7 >